Artigos de revistas sobre o tema "Il-33 vih"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Il-33 vih".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
S, Traoré. "Survie des personnes vivant avec le VIH et le Sida suivies dans les 17 sites de traitement antirétroviral au Mali". Mali Santé Publique 10, n.º 02 (20 de abril de 2021): 44–49. http://dx.doi.org/10.53318/msp.v10i02.1796.
Texto completo da fonteKeita, BB, e Et Al. "Facteurs associés au décès des personnes infectées par le virus de l’immunodéficience humaine sous traitement antirétroviral au Centre Walé de Ségou, Mali." Revue Malienne d'Infectiologie et de Microbiologie 18, n.º 2 (8 de janeiro de 2024): 38–49. http://dx.doi.org/10.53597/remim.v18i2.2733.
Texto completo da fonteAbdourahimi, D., D. Yehadji, E. Briskin, E. M. Khine, C. Arias, K. S. André, F. K. Mukebela et al. "Facteurs associés à la létalité chez les patients hospitalisés pour le VIH avancé". Public Health Action 13, n.º 2 (1 de agosto de 2023): 19–24. http://dx.doi.org/10.5588/pha.23.0009.
Texto completo da fonteBeye, SA, e Et Al. "Prévalence des infections nosocomiales au Centre Hospitalier Universitaire du Point G de Bamako, Mali." Revue Malienne d'Infectiologie et de Microbiologie 19, n.º 1 (13 de março de 2024): 45–49. http://dx.doi.org/10.53597/remim.v19i1.2794.
Texto completo da fonteUsman, S. O., O. M. Ajayi, O. Ebiekura, N. Egbonrelu, G. Ebhojie e A. O. Ariyo. "Evidence of virological failure in patients on second-line anti-retroviral therapy in Southwestern Nigeria: An indication for HIV drug resistance testing". African Journal of Clinical and Experimental Microbiology 22, n.º 3 (2 de julho de 2021): 415–19. http://dx.doi.org/10.4314/ajcem.v22i3.13.
Texto completo da fonteMathias, Clinton B., Jeffrey Rovatti e Stephanie Polukort. "IL-10 enhances IgE-independent IL-33-mediated mast cell cytokine production". Journal of Immunology 198, n.º 1_Supplement (1 de maio de 2017): 145.8. http://dx.doi.org/10.4049/jimmunol.198.supp.145.8.
Texto completo da fonteMiller, Ashley M., Damo Xu, Darren L. Asquith, Laura Denby, Yubin Li, Naveed Sattar, Andrew H. Baker, Iain B. McInnes e Foo Y. Liew. "IL-33 reduces the development of atherosclerosis". Journal of Experimental Medicine 205, n.º 2 (11 de fevereiro de 2008): 339–46. http://dx.doi.org/10.1084/jem.20071868.
Texto completo da fontePark, Su-Ho, Myun Soo Kim, Hui Xuan Lim, Daeho Cho e Tae Sung Kim. "IL-33-matured dendritic cells promote Th17 cell responses via IL-1β and IL-6". Cytokine 99 (novembro de 2017): 106–13. http://dx.doi.org/10.1016/j.cyto.2017.07.022.
Texto completo da fonteNagashima, Ryuichi, Hiroki Ishikawa, Yoshihiro Kuno, Chikara Kohda e Masayuki Iyoda. "IL-33 attenuates renal fibrosis via group2 innate lymphoid cells". Cytokine 157 (setembro de 2022): 155963. http://dx.doi.org/10.1016/j.cyto.2022.155963.
Texto completo da fonteWang, J. X., S. Kaieda, S. Ameri, N. Fishgal, D. Dwyer, A. Dellinger, C. L. Kepley, M. F. Gurish e P. A. Nigrovic. "IL-33/ST2 axis promotes mast cell survival via BCLXL". Proceedings of the National Academy of Sciences 111, n.º 28 (30 de junho de 2014): 10281–86. http://dx.doi.org/10.1073/pnas.1404182111.
Texto completo da fonteTsuji, Gaku, Akiko Hashimoto-Hachiya, Vu Hai Yen, Sho Miake, Masaki Takemura, Yasutaka Mitamura, Takamichi Ito, Maho Murata, Masutaka Furue e Takeshi Nakahara. "Aryl Hydrocarbon Receptor Activation Downregulates IL-33 Expression in Keratinocytes via Ovo-Like 1". Journal of Clinical Medicine 9, n.º 3 (24 de março de 2020): 891. http://dx.doi.org/10.3390/jcm9030891.
Texto completo da fonteDuan, Lihua, Jie Chen, Feili Gong e Guixiu Shi. "The Role of IL-33 in Rheumatic Diseases". Clinical and Developmental Immunology 2013 (2013): 1–5. http://dx.doi.org/10.1155/2013/924363.
Texto completo da fonteGarth, Jaleesa M., Kristen M. Reeder, Joseph Mackel, Chad Dunaway, Jonathan Blackburn e Chad Steele. "IL-33 signaling regulates innate IL-22 production via suppression of PGE2 during lung fungal infection". Journal of Immunology 198, n.º 1_Supplement (1 de maio de 2017): 131.20. http://dx.doi.org/10.4049/jimmunol.198.supp.131.20.
Texto completo da fonteTsuji, Gaku, Kazuhiko Yamamura, Koji Kawamura, Makiko Kido-Nakahara, Takamichi Ito e Takeshi Nakahara. "Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis". International Journal of Molecular Sciences 24, n.º 19 (27 de setembro de 2023): 14633. http://dx.doi.org/10.3390/ijms241914633.
Texto completo da fonteSong, Yitian, Fangzhi Wei, Ying Liu, Feng Han, Lihui Ma, Yanping Zhuang, Chengdan Pan, Zhandong Jia e Aimin Gong. "IL-33/ST2 Activation Is involved in Ro60-Regulated Photosensitivity in Cutaneous Lupus Erythematosus". Mediators of Inflammation 2022 (20 de julho de 2022): 1–15. http://dx.doi.org/10.1155/2022/4955761.
Texto completo da fonteSuzukawa, Maho, Motoyasu Iikura, Rikiya Koketsu, Hiroyuki Nagase, Chise Tamura, Akiko Komiya, Susumu Nakae et al. "An IL-1 Cytokine Member, IL-33, Induces Human Basophil Activation via Its ST2 Receptor". Journal of Immunology 181, n.º 9 (20 de outubro de 2008): 5981–89. http://dx.doi.org/10.4049/jimmunol.181.9.5981.
Texto completo da fonteChalubinski, Maciej, Katarzyna Wojdan, Emilia Luczak, Paulina Gorzelak, Maciej Borowiec, Adrian Gajewski, Karolina Rudnicka, Magdalena Chmiela e Marlena Broncel. "IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms". Vascular Pharmacology 73 (outubro de 2015): 57–63. http://dx.doi.org/10.1016/j.vph.2015.07.012.
Texto completo da fonteTsai, Mei-Lan, Ming-Kai Tsai, Yi-Giien Tsai, Yu-Chih Lin, Ya-Ling Hsu, Yi-Ting Chen, Yi-Ching Lin e Chih-Hsing Hung. "Montelukast Increased IL-25, IL-33, and TSLP via Epigenetic Regulation in Airway Epithelial Cells". International Journal of Molecular Sciences 24, n.º 2 (8 de janeiro de 2023): 1227. http://dx.doi.org/10.3390/ijms24021227.
Texto completo da fonteYANGNGAM, SUPAPORN, SUYANEE THONGCHOT, KULTHIDA VAETEEWOOTTACHARN, PETI THUWAJIT, MARCELA A. HERMOSO, SEIJI OKADA e CHANITRA THUWAJIT. "Intracellular IL-33 Attenuates Extracellular IL-33-induced Cholangiocarcinoma Cell Proliferation and Invasion via NF-κB and GSK-3β Pathways". Anticancer Research 41, n.º 10 (30 de setembro de 2021): 4917–28. http://dx.doi.org/10.21873/anticanres.15305.
Texto completo da fonteDuan, Lihua, Yan Huang, Qun Su, Qingyan Lin, Wen Liu, Jiao Luo, Bing Yu et al. "Potential of IL-33 for Preventing the Kidney Injury via Regulating the Lipid Metabolism in Gout Patients". Journal of Diabetes Research 2016 (2016): 1–7. http://dx.doi.org/10.1155/2016/1028401.
Texto completo da fonteDuez, Catherine, Barbara Gross, Philippe Marquillies, Valérie Ledroit, Bernhard Ryffel e Corine Glineur. "Regulation of IL (Interleukin)-33 Production in Endothelial Cells via Kinase Activation and Fas/CD95 Upregulation". Arteriosclerosis, Thrombosis, and Vascular Biology 40, n.º 11 (novembro de 2020): 2619–31. http://dx.doi.org/10.1161/atvbaha.120.314832.
Texto completo da fonteMahlakõiv, T., A. L. Flamar, L. K. Johnston, S. Moriyama, G. G. Putzel, P. J. Bryce e D. Artis. "Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33". Science Immunology 4, n.º 35 (3 de maio de 2019): eaax0416. http://dx.doi.org/10.1126/sciimmunol.aax0416.
Texto completo da fonteSuzukawa, Maho, Masao Yamaguchi, Motoyasu Iikura, Rikiya Koketsu, Akiko Komiya, Hiroyuki Nagase, Susumu Nakae et al. "IL-33-induced activation of human basophils and eosinophils via ST2". Inflammation and Regeneration 30, n.º 3 (2010): 181–85. http://dx.doi.org/10.2492/inflammregen.30.181.
Texto completo da fonteHsu, Chia-Lin, e Paul Bryce. "IL-33 expression by mast cells is regulated by a Sphk-calcium-NFAT dependent pathway (117.5)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 117.5. http://dx.doi.org/10.4049/jimmunol.186.supp.117.5.
Texto completo da fonteXiao, Yi, Feidi Chen, Ye Zhao, Mingming Sun, Xiangsheng Huang, Liang Chen, Suxia Yao et al. "Interleukin-33 promotes REG3γ expression in intestinal epithelial cells via activation of mTOR, STAT3 and ERK1/2". Journal of Immunology 198, n.º 1_Supplement (1 de maio de 2017): 200.12. http://dx.doi.org/10.4049/jimmunol.198.supp.200.12.
Texto completo da fonteLiang, Yuejin, Panpan Yi, Zuliang Jie, Denley Denley Ming Kee Yuan, Lynn Soong, Yingzi Cong e Jiaren Sun. "IL-33 promotes antiviral CD8+ T cells through the mTORC1 pathway and limits liver injury via recruiting immunosuppressive neutrophils". Journal of Immunology 198, n.º 1_Supplement (1 de maio de 2017): 78.3. http://dx.doi.org/10.4049/jimmunol.198.supp.78.3.
Texto completo da fonteReichenbach, Dawn K., Vincent Schwarze, Benjamin M. Matta, Victor Tkachev, Elizabeth Lieberknecht, Quan Liu, Brent H. Koehn et al. "Regulation of Immune Responses during Acute GvHD Via the IL-33/ST2 Axis". Blood 124, n.º 21 (6 de dezembro de 2014): 844. http://dx.doi.org/10.1182/blood.v124.21.844.844.
Texto completo da fonteSaxton, Sophie N., Alice S. Whitley, Ryan J. Potter, Sarah B. Withers, Richard Grencis e Anthony M. Heagerty. "Interleukin-33 rescues perivascular adipose tissue anticontractile function in obesity". American Journal of Physiology-Heart and Circulatory Physiology 319, n.º 6 (1 de dezembro de 2020): H1387—H1397. http://dx.doi.org/10.1152/ajpheart.00491.2020.
Texto completo da fonteWaddell, Amanda, Jefferson E. Vallance, Amy Hummel, Theresa Alenghat e Michael J. Rosen. "IL-33 Induces Murine Intestinal Goblet Cell Differentiation Indirectly via Innate Lymphoid Cell IL-13 Secretion". Journal of Immunology 202, n.º 2 (7 de dezembro de 2018): 598–607. http://dx.doi.org/10.4049/jimmunol.1800292.
Texto completo da fonteDai, Xiuju, Mikiko Tohyama, Masamoto Murakami, Yasushi Hanakawa e Koji Sayama. "House dust mite allergen releases IL-31 and IL-33 from epidermal keratinocytes via ATP signaling". Journal of Dermatological Science 84, n.º 1 (outubro de 2016): e70-e71. http://dx.doi.org/10.1016/j.jdermsci.2016.08.218.
Texto completo da fonteCheng, Li, Yang Jiao, Wei Jiang, Xin Zhang, Liping Zhang e Gongwei Jia. "IL-33 Deficiency Attenuates Lung Inflammation by Inducing Th17 Response and Impacting the Th17/Treg Balance in LPS-Induced ARDS Mice via Dendritic Cells". Journal of Immunology Research 2022 (16 de dezembro de 2022): 1–12. http://dx.doi.org/10.1155/2022/9543083.
Texto completo da fonteDagher, Rania, Alan M. Copenhaver, Valerie Besnard, Marielle Maret, Fatima Hamidi, Aaron A. Berlin, Michel Aubier, Roland Kolbeck, Alison A. Humbles e Marina Pretolani. "IL-33/ST2 macrophage crosstalk promotes lung epithelial repair". Journal of Immunology 198, n.º 1_Supplement (1 de maio de 2017): 211.13. http://dx.doi.org/10.4049/jimmunol.198.supp.211.13.
Texto completo da fonteYang, Fuhan, Mingming Wen, Dayu Pan, Xian Lin, Jing Mo, Xueyi Dong, Shihan Liao e Yuemei Ma. "IL-33/ST2 Axis Regulates Vasculogenic Mimicry via ERK1/2-MMP-2/9 Pathway in Melanoma". Dermatology 235, n.º 3 (2019): 225–33. http://dx.doi.org/10.1159/000498857.
Texto completo da fonteMohd Jaya, Fatin Nurizzati, Zhongyi Liu e Godfrey Chi-Fung Chan. "Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice". Cells 9, n.º 11 (10 de novembro de 2020): 2448. http://dx.doi.org/10.3390/cells9112448.
Texto completo da fonteZhao, Qing, e Guangjie Chen. "Role of IL-33 and Its Receptor in T Cell-Mediated Autoimmune Diseases". BioMed Research International 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/587376.
Texto completo da fonteMeiners, Jana, Martina Reitz, Nikolas Rüdiger, Jan-Eric Turner, Lennart Heepmann, Lena Rudolf, Wiebke Hartmann, Henry J. McSorley e Minka Breloer. "IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation". PLOS Pathogens 16, n.º 12 (22 de dezembro de 2020): e1009121. http://dx.doi.org/10.1371/journal.ppat.1009121.
Texto completo da fonteStill, Katherine M., Samantha J. Batista, Carleigh A. O’Brien, Oyebola O. Oyesola, Simon P. Früh, Lauren M. Webb, Igor Smirnov et al. "Astrocytes promote a protective immune response to brain Toxoplasma gondii infection via IL-33-ST2 signaling". PLOS Pathogens 16, n.º 10 (27 de outubro de 2020): e1009027. http://dx.doi.org/10.1371/journal.ppat.1009027.
Texto completo da fonteTembhre, Manoj Kumar, Mukesh Kumar Sriwastva, Milind Padmakar Hote, Shikha Srivastava, Priyanka Solanki, Shafaque Imran, Ramakrishnan Lakshmy, Alpana Sharma, Kailash Jaiswal e Ashish Datt Upadhyay. "Interleukin-33 Induces Neutrophil Extracellular Trap (NET) Formation and Macrophage Necroptosis via Enhancing Oxidative Stress and Secretion of Proatherogenic Factors in Advanced Atherosclerosis". Antioxidants 11, n.º 12 (26 de novembro de 2022): 2343. http://dx.doi.org/10.3390/antiox11122343.
Texto completo da fonteChen, Zuojia, Jialie Luo, Jian Li, Girak Kim, Andy Stewart, Yuefeng Huang e Chuan Wu. "Intestinal IL-33 promotes platelet activity for neutrophil recruitment during acute inflammation". Blood 139, n.º 12 (24 de março de 2022): 1878–91. http://dx.doi.org/10.1182/blood.2021013474.
Texto completo da fonteLv, Ran, Jinning Zhao, Min Lei, Dongju Xiao, Yijin Yu e Junran Xie. "IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3". Cellular Physiology and Biochemistry 42, n.º 5 (2017): 1961–72. http://dx.doi.org/10.1159/000479836.
Texto completo da fonteLin, Yu-Chun, Wen-Yen Huang, Tsai-Yu Lee, Yi-Ming Chang, Su-Feng Chen, Yaoh-Shiang Lin e Shin Nieh. "Interleukin-33-Enhanced CXCR4 Signaling Circuit Mediated by Carcinoma-Associated Fibroblasts Promotes Invasiveness of Head and Neck Cancer". Cancers 13, n.º 14 (9 de julho de 2021): 3442. http://dx.doi.org/10.3390/cancers13143442.
Texto completo da fonteUmebashi, Katsuyuki, Masayoshi Yamamoto, Akinori Tokito, Ku Sudou, Yoko Takenoshita e Michihisa Jougasaki. "Inhibitory Effects of Simvastatin on IL-33-Induced MCP-1 via the Suppression of the JNK Pathway in Human Vascular Endothelial Cells". International Journal of Molecular Sciences 24, n.º 16 (21 de agosto de 2023): 13015. http://dx.doi.org/10.3390/ijms241613015.
Texto completo da fonteLi, Shu, Feng-xue Zhu, Hong-bin Zhang, Hui Li e You-zhong An. "Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice". Chinese Medical Journal 126, n.º 10 (20 de maio de 2013): 1855–59. http://dx.doi.org/10.3760/cma.j.issn.0366-6999.20123530.
Texto completo da fonteZhu, Xiaoqing, Yinghua Zhao, Yuxue Jiang, Tianxue Qin, Jintong Chen, Xiao Chu, Qing Yi, Sujun Gao e Siqing Wang. "Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1". Oncotarget 8, n.º 32 (8 de junho de 2017): 53366–74. http://dx.doi.org/10.18632/oncotarget.18411.
Texto completo da fonteTravers, Jared, Mark Rochman, Cora E. Miracle, Jared P. Cohen e Marc E. Rothenberg. "Linking impaired skin barrier function to esophageal allergic inflammation via IL-33". Journal of Allergy and Clinical Immunology 138, n.º 5 (novembro de 2016): 1381–83. http://dx.doi.org/10.1016/j.jaci.2016.09.001.
Texto completo da fonteOno, Yosuke, Osamu Yoshino, Takehiro Hiraoka, Ikumi Akiyama, Erina Sato, Masami Ito, Mutsumi Kobayashi et al. "IL-33 Exacerbates Endometriotic Lesions via Polarizing Peritoneal Macrophages to M2 Subtype". Reproductive Sciences 27, n.º 3 (7 de janeiro de 2020): 869–76. http://dx.doi.org/10.1007/s43032-019-00090-9.
Texto completo da fonteGarth, Jaleesa M., Kristen M. Reeder, Matthew S. Godwin, Joseph J. Mackel, Chad W. Dunaway, Jonathan P. Blackburn e Chad Steele. "IL-33 Signaling Regulates Innate IL-17A and IL-22 Production via Suppression of Prostaglandin E2 during Lung Fungal Infection". Journal of Immunology 199, n.º 6 (7 de agosto de 2017): 2140–48. http://dx.doi.org/10.4049/jimmunol.1602186.
Texto completo da fonteHoward, Chanie L., Donna C. Decker, Ivy Aneas Swanson, Kelly M. Blaine, Marcelo A. Nobrega e Anne I. Sperling. "A novel role of human lung endothelial cells in allergic airway disease by producing and responding to IL-33". Journal of Immunology 200, n.º 1_Supplement (1 de maio de 2018): 44.17. http://dx.doi.org/10.4049/jimmunol.200.supp.44.17.
Texto completo da fonteChoi, Yeon-Sook, Hyun-Jung Choi, Jeong-Ki Min, Bo-Jeong Pyun, Yong-Sun Maeng, Hongryeol Park, Jihye Kim, Young-Myeong Kim e Young-Guen Kwon. "Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production". Blood 114, n.º 14 (1 de outubro de 2009): 3117–26. http://dx.doi.org/10.1182/blood-2009-02-203372.
Texto completo da fonteMatta, Benjamin, Jeremy Lott, Lisa Mathews, Brian Rosborough, Bruce Blazar e Heth Turnquist. "IL-33 stimulates dendritic cell secretion of IL-2 that promotes selective expansion of ST2+Foxp3+ regulatory T cells (IRC5P.460)". Journal of Immunology 192, n.º 1_Supplement (1 de maio de 2014): 125.9. http://dx.doi.org/10.4049/jimmunol.192.supp.125.9.
Texto completo da fonte